
Opinion|Videos|January 31, 2024
Use of Subsequent Therapies in SR/D cGvHD
Author(s)Robert Zeiser, MD, Nelson J. Chao, MD
Experts discuss the treatments for steroid-refractory/dependent chronic Graft vs Host Disease (SR/D cGvHD), focusing on the unique mechanisms and applications of belumosudil and role of ibrutinib.
Episodes in this series

















